Annual ROE
-19.92%
+4.54%+18.56%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual return on equity is -19.92%, with the most recent change of +4.54% (+18.56%) on December 31, 2023.
- During the last 3 years, AUPH annual ROE has risen by +9.15% (+31.48%).
- AUPH annual ROE is now -107.62% below its all-time high of 261.52%, reached on November 30, 1998.
Performance
AUPH ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-5.99%
+7.36%+55.13%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly return on equity is -5.99%, with the most recent change of +7.36% (+55.13%) on September 30, 2024.
- Over the past year, AUPH quarterly ROE has increased by +7.36% (+55.13%).
- AUPH quarterly ROE is now -100.99% below its all-time high of 604.45%, reached on June 30, 2013.
Performance
AUPH Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AUPH ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.6% | +55.1% |
| 3 y3 years | +31.5% | +78.5% |
| 5 y5 years | +47.8% | +78.5% |
AUPH ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +51.2% | at high | +87.5% |
| 5 y | 5-year | at high | +53.7% | at high | +89.2% |
| alltime | all time | -107.6% | +95.6% | -101.0% | +99.2% |
Aurinia Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -5.99%(-55.1%) |
| Jun 2024 | - | -13.35%(-18.4%) |
| Mar 2024 | - | -16.36%(-17.9%) |
| Dec 2023 | -19.92%(-18.6%) | -19.92%(+3.4%) |
| Sep 2023 | - | -19.26%(+7.8%) |
| Jun 2023 | - | -17.87%(-22.7%) |
| Mar 2023 | - | -23.13%(-6.8%) |
| Dec 2022 | -24.46%(-40.1%) | -24.81%(-10.9%) |
| Sep 2022 | - | -27.85%(-29.6%) |
| Jun 2022 | - | -39.55%(-9.4%) |
| Mar 2022 | - | -43.63%(-9.0%) |
| Dec 2021 | -40.81%(+40.4%) | -47.94%(+11.3%) |
| Sep 2021 | - | -43.08%(+2.1%) |
| Jun 2021 | - | -42.21%(+11.5%) |
| Mar 2021 | - | -37.85%(+18.5%) |
| Dec 2020 | -29.07%(-32.4%) | -31.94%(-37.7%) |
| Sep 2020 | - | -51.23%(-4.3%) |
| Jun 2020 | - | -53.55%(-0.0%) |
| Mar 2020 | - | -53.57%(-3.0%) |
| Dec 2019 | -42.99%(+12.7%) | -55.23%(+36.0%) |
| Sep 2019 | - | -40.61%(+4.4%) |
| Jun 2019 | - | -38.91%(+4.5%) |
| Mar 2019 | - | -37.23%(-2.1%) |
| Dec 2018 | -38.14%(-45.7%) | -38.01%(+8.4%) |
| Sep 2018 | - | -35.08%(+18.8%) |
| Jun 2018 | - | -29.53%(+44.0%) |
| Mar 2018 | - | -20.51%(-58.3%) |
| Dec 2017 | -70.20%(-15.8%) | -49.13%(-25.5%) |
| Sep 2017 | - | -65.93%(-19.7%) |
| Jun 2017 | - | -82.13%(-38.8%) |
| Mar 2017 | - | -134.27%(+28.6%) |
| Dec 2016 | -83.33%(+20.5%) | -104.39%(+8.8%) |
| Sep 2016 | - | -95.92%(+22.2%) |
| Jun 2016 | - | -78.52%(+26.6%) |
| Mar 2016 | - | -62.00%(-11.4%) |
| Dec 2015 | -69.13%(-16.0%) | -69.98%(+0.3%) |
| Sep 2015 | - | -69.78%(+103.8%) |
| Jun 2015 | - | -34.24%(-36.4%) |
| Mar 2015 | - | -53.83%(+11.8%) |
| Dec 2014 | -82.32%(+73.1%) | -48.16%(+33.1%) |
| Sep 2014 | - | -36.19%(-44.4%) |
| Jun 2014 | - | -65.12%(+45.6%) |
| Mar 2014 | - | -44.73%(-40.8%) |
| Dec 2013 | -47.56%(-89.5%) | -75.58%(-84.0%) |
| Sep 2013 | - | -471.17%(-178.0%) |
| Jun 2013 | - | 604.45%(-185.9%) |
| Mar 2013 | - | -703.35%(+139.4%) |
| Dec 2012 | -453.60%(+1101.9%) | -293.79%(+68.4%) |
| Sep 2012 | - | -174.41%(+99.5%) |
| Jun 2012 | - | -87.43%(-3014.3%) |
| Mar 2012 | - | 3.00%(-111.1%) |
| Dec 2011 | -37.74% | -27.07%(-171.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | 37.87%(-223.9%) |
| Jun 2011 | - | -30.57%(-75.2%) |
| Mar 2011 | - | -123.02%(+96.0%) |
| Dec 2010 | -68.52%(-42.8%) | -62.78%(-19.1%) |
| Sep 2010 | - | -77.58%(+51.6%) |
| Jun 2010 | - | -51.16%(+4.0%) |
| Mar 2010 | - | -49.18%(-57.4%) |
| Dec 2009 | -119.86%(+36.9%) | -115.46%(+19.0%) |
| Sep 2009 | - | -97.04%(+4.6%) |
| Jun 2009 | - | -92.75%(-14.4%) |
| Mar 2009 | - | -108.32%(+20.4%) |
| Dec 2008 | -87.54%(-37.1%) | -90.00%(-5.3%) |
| Sep 2008 | - | -95.04%(+5.0%) |
| Jun 2008 | - | -90.48%(+4.0%) |
| Mar 2008 | - | -87.04%(-6.1%) |
| Dec 2007 | -139.24%(+90.5%) | -92.70%(+9.1%) |
| Sep 2007 | - | -84.96%(+2.5%) |
| Jun 2007 | - | -82.92%(+11.3%) |
| Mar 2007 | - | -74.51%(+6.7%) |
| Dec 2006 | -73.10%(+18.9%) | -69.84%(+9.3%) |
| Sep 2006 | - | -63.89%(+2.7%) |
| Jun 2006 | - | -62.24%(+3.6%) |
| Mar 2006 | - | -60.08%(-2.3%) |
| Dec 2005 | -61.50%(+64.6%) | -61.48%(+3.6%) |
| Sep 2005 | - | -59.35%(+3.1%) |
| Jun 2005 | - | -57.55%(+23.1%) |
| Mar 2005 | - | -46.75%(+27.8%) |
| Dec 2004 | -37.37%(+48.1%) | -36.59%(+16.8%) |
| Sep 2004 | - | -31.34%(+16.6%) |
| Jun 2004 | - | -26.87%(+28.7%) |
| Mar 2004 | - | -20.87%(-13.2%) |
| Dec 2003 | -25.23%(+2767.0%) | -24.03%(+30.0%) |
| Sep 2003 | - | -18.49%(+196.3%) |
| Jun 2003 | - | -6.24%(+28.1%) |
| Mar 2003 | - | -4.87%(+673.0%) |
| Dec 2002 | -0.88%(-97.1%) | -0.63%(-158.3%) |
| Sep 2002 | - | 1.08%(-105.5%) |
| Jun 2002 | - | -19.53%(-59.9%) |
| Mar 2002 | - | -48.76%(-28.4%) |
| Dec 2001 | -30.83%(-60.9%) | - |
| Aug 2001 | - | -68.13%(-14.8%) |
| May 2001 | - | -79.98%(+6.3%) |
| Feb 2001 | - | -75.23%(+2.2%) |
| Nov 2000 | -78.81%(-24.4%) | -73.58%(-4.1%) |
| Aug 2000 | - | -76.73%(-3.2%) |
| May 2000 | - | -79.26%(-24.3%) |
| Feb 2000 | - | -104.75%(+22.2%) |
| Nov 1999 | -104.24%(-139.9%) | -85.71%(+112.9%) |
| Aug 1999 | - | -40.25%(-17.4%) |
| May 1999 | - | -48.75%(-733.9%) |
| Feb 1999 | - | 7.69% |
| Nov 1998 | 261.52% | - |
FAQ
- What is Aurinia Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual ROE year-on-year change?
- What is Aurinia Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly ROE year-on-year change?
What is Aurinia Pharmaceuticals annual return on equity?
The current annual ROE of AUPH is -19.92%
What is the all time high annual ROE for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual return on equity is 261.52%
What is Aurinia Pharmaceuticals annual ROE year-on-year change?
Over the past year, AUPH annual return on equity has changed by +4.54% (+18.56%)
What is Aurinia Pharmaceuticals quarterly return on equity?
The current quarterly ROE of AUPH is -5.99%
What is the all time high quarterly ROE for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly return on equity is 604.45%
What is Aurinia Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, AUPH quarterly return on equity has changed by +7.36% (+55.13%)